CD8A and neoplasm: To understand the role of LPA in the context of anti-tumor immunity, we performed adoptive transfers using a systemic tumor model with the hypothesis that Lpar5 receptor knockout (Lpar5−/−) CD8 T cells also display an enhanced ability to kill tumor cells systemically in vivo.